An alternative explanation, which seems more likely in the light of recent studies, is that the difference is neuropharmacological, since the same phenomenon can be reproduced in a well-characterized tau transgenic mouse model for AD [32]. The gene discussed is MAPT; the disease is Alzheimer disease.